Skip to main content
Todd Rosenblat, MD, Hematology, New York, NY, New York-Presbyterian Hospital

ToddLouisRosenblatMD

Hematology • New York, NY

Hematologic Oncology

Assistant Professor of Medicine at Columbia University Medical Center, Div. of Hematology/Oncology New York-Presbyterian Hospital/Columbia University Medical Center

Request Appointment

Overview of Dr. Rosenblat

Dr. Todd Rosenblat is a hematologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, NewYork-Presbyterian/Columbia University Irving Medical Center, and Memorial Sloan Kettering Cancer Center. He received his medical degree from Stony Brook University Health Sciences Center School of Medicine and has been in practice 14 years. Dr. Rosenblat accepts several types of health insurance, listed below. He is one of 60 doctors at Memorial Sloan Kettering Cancer Center and one of 60 doctors at New York-Presbyterian Hospital who specialize in Hematology. He has more than 20 publications and over 500 citings.

Education & Training

  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2006 - 2009
  • NYU Grossman School of Medicine
    NYU Grossman School of MedicineResidency, Internal Medicine, 2003 - 2006
  • Stony Brook University Health Sciences Center School of Medicine
    Stony Brook University Health Sciences Center School of MedicineClass of 2003

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2004 - 2026
  • American Board of Internal Medicine Hematology

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Landmark Response and Survival Analyses from 102 MDS and CMML Patients Treated with Guadecitabine in a Phase 2 Study Showing That Maximum Response and Survival Is Best...
    Todd L. Rosenblat, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Landmark Response and Survival Analyses from 206 AML Patients Treated with Guadecitabine in a Phase 2 Study Demonstrate the Importance of Adequate Treatment Duration t...
    Todd L. Rosenblat, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Combination Thioguanine and Decitabine Is Highly Active in Patients with Advanced Myeloid Malignancies: A Single Institution Experience
    Todd L. Rosenblat, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

  • Long Term Results of a Randomized Phase 2 Dose-Response Study of Guadecitabine, a Novel Subcutaneous (SC) Hypomethylating Agent (HMA), in 102 Patients with Intermediat... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Hospital Affiliations

Insurance Accepted

  • Aetna Choice POS II
    Aetna HMO
    BCBS Blue Card PPO
    CIGNA HMO
    CIGNA Open Access
    CIGNA PPO
    Empire BCBS HMO
    Empire BCBS PPO
    GHI PPO
    Great West PPO
    Multiplan PHCS PPO
    Multiplan PPO
    MVP Healthcare PPO
    Oxford Health Freedom
    Oxford Health Liberty
    QualCare HMO
    QualCare PPO
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
  • Please verify your coverage with the provider's office directly when scheduling an appointment

Dr. Todd Rosenblat, Dr. Todd Rosenblat, MD, Dr. T Rosenblat, Dr. Todd Louis Rosenblat